1. Home
  2. SG vs TNDM Comparison

SG vs TNDM Comparison

Compare SG & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sweetgreen Inc.

SG

Sweetgreen Inc.

N/A

Current Price

$11.99

Market Cap

1.2B

ML Signal

N/A

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

N/A

Current Price

$16.78

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SG
TNDM
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
SG
TNDM
Price
$11.99
$16.78
Analyst Decision
Buy
Buy
Analyst Count
14
25
Target Price
$9.45
★ $27.76
AVG Volume (30 Days)
★ 4.3M
2.1M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.57
N/A
Revenue
$679,474,000.00
★ $1,014,736,000.00
Revenue This Year
$0.98
$5.69
Revenue Next Year
$8.18
$12.35
P/E Ratio
$14.62
★ N/A
Revenue Growth
0.39
★ 7.93
52 Week Low
$4.49
$12.26
52 Week High
$11.99
$29.65

Technical Indicators

Market Signals
Indicator
SG
TNDM
Relative Strength Index (RSI) 66.57 45.28
Support Level $6.24 $14.66
Resistance Level N/A $18.13
Average True Range (ATR) 0.71 1.13
MACD 0.03 -0.01
Stochastic Oscillator 70.63 33.02

Price Performance

Historical Comparison
SG
TNDM

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Its menu involves, Kids' meal, salads, sides, local items, Protein Plates, Desserts, Drinks and Others.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: